| 11.53 |  +0.04 / +0.35% |
Data as of 4:00pm ET | Day’s Change |
| 11.53 |  0.00 / 0.00% |
Volume: 0.00 |
| Solazyme Whiffs on Revenues May 09 / MotleyFool.com |
| Previous close | 11.49 |
| Today’s open | 11.40 |
| Day’s range | 11.14 - 11.76 |
| Volume | 747,843 |
| Average volume (3 months) | 604,848 |
| Market cap | $710.4M |
| Dividend yield | -- |
| Earnings growth (last year) | -1.48% |
| Earnings growth (this year) | -13.55% |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | +13.20% |
| P/E ratio | NM |
| Price/Sales | 10.78 |
| Price/Book | 3.82 |
| Today’s change | Today’s % change | |
|---|---|---|
| MNTAMomenta Pharmaceutic... | +0.21 | +1.63% |
| ITMNInterMune Inc | -0.14 | -1.38% |
| HALOHalozyme Therapeutic... | +0.02 | +0.26% |
| PLXProtalix Biotherapeu... | +0.01 | +0.19% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $44.1M |
| Annual profit (last year) | -$83.1M |
| Net profit margin | -188.47% |
Sector Process Industries |
Industry Chemicals: Specialty |
President & Director Harrison F. Dillon, PhD |
Chief Executive Officer & Director Jonathan S. Wolfson, MBA |
Corporate headquarters San Francisco, California |
.
